Lisette Hilton

The oral beta-3 agonist vibegron, taken once daily at either 50 mg or 100 mg, is well tolerated and results in clinically and statistically significant reductions in daily micturitions, urge incontinence, and urgency episodes.

A nickel-sized leadless titanium device, implanted in patients’ ankles, could provide years of relief from overactive bladder syndrome.

There were significant improvements among those studied on the higher radiation dose in terms of biochemical failure and distant metastases, however.

Enhanced Recovery After Surgery, or ERAS, is radically changing and standardizing preoperative, perioperative, and postoperative approaches to major surgeries, including radical cystectomy. And while the changes can seem troublesome at first, urologic surgeons who perform radical cystectomy say letting go of dogma is worth it for patients, physicians, and staff.

Researchers have reported an association with the release of the AUA/SUFU Adult Urodynamics Guideline and reduction of urodynamics performed for diagnosis of overactive bladder, stress urinary incontinence, and mixed urinary incontinence.

Men and women with gout are at 60% greater risk for nephrolithiasis than adults without gout, according to a study looking at not only the chronic kidney condition’s incidence but also potential risk factors for first-time nephrolithiasis in people with and without gout.

Study findings serve as a reminder of the importance of prompt and direct physical therapy referrals for pelvic floor pain patients, researchers say.

The results could have major diagnostic and treatment implications for pediatric kidney stone patients, a researcher says.

Whether or not medical expulsive therapy (MET) is a sound recommendation for patients with kidney or ureteral stones is a matter of debate.

FDA approval of second-line therapies could mean an “embarrassment of riches” in this field, according to one expert.

Urologist Peter Black, MD, discusses the recent FDA approval of atezolizumab (TECENTRIQ) for the most common form of bladder cancer as well as a complementary diagnostic test.

Once considered a primary option for kidney stone treatment, shock wave lithotripsy appears to be losing traction. Many urologists say its outcomes aren’t as reliable as those from ureteroscopy. But others say it remains an option that works well with proper patient selection and technique and offers what ureteroscopy doesn’t: a noninvasive option.

Work-related risks for bladder cancer are on the rise, but the occupations putting workers at risk seem to be evolving, according to a meta-analysis published online in JAMA Oncology (Oct. 8, 2015).

Study findings point to “a concept that has haunted clinical trialists for years,” says one expert.

Researchers compared artery thickness in children with and without kidney stones.

A new study on the use of a reflux calculator, developed at Children’s Hospital of Orange County in Irvine, CA, suggests the web-based risk stratification and probability model helps to predict vesicoureteral reflux patients’ 2-year risk of breakthrough urinary tract infection.

One in 30 women treated for stress urinary incontinence with synthetic mesh slings might require mesh removal or revision 10 years post-SUI mesh surgery.

While there is no benefit from using tamsulosin (Flomax) versus placebo for the treatment of small ureteral stones, there is a potential upside of increased passage from using the drug to treat 5- to 10-mm stones, according to a study from Australia published online in the Annals of Emergency Medicine (July 13, 2015).

A large, multicenter study “definitively demonstrates” the treatment’s infectiveness, one expert says.

The study shows a wide discrepancy between the least and most expensive ways to treat the common prostate condition.

Research on the quality of bladder biopsy and bladder cancer survival point to problems of suboptimal biopsies and incorrect tumor staging, researchers say.

Ann Arbor, MI-Evidence-based expectant management of men with lower-risk prostate cancer does not seem to be catching on among physicians and their patients. A new study suggests that, among men who are appropriate candidates for the wait-and-see approach, physicians are treating more than half with surgery or radiation therapy.

Atlanta-Patients who undergo radical prostatectomy for clinical stage T4 prostate cancer have a higher survival rate than do patients who receive radiation or hormone therapies alone, and surgical prostate cancer patients' survival is comparable to that of patients who receive both hormone and radiation therapies.

Orlando, FL-In the throes of the PSA era, with stage migration and improved therapies, the impact of family history on prostate cancer prognosis has become minimal, according to a new study.